Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

How does trial enrollment work? Does big pharma ki

Message Board Public Reply | Private Reply | Keep | Replies (2)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 155128
(Total Views: 645)
Posted On: 04/30/2020 4:37:06 PM
Avatar
Posted By: Goosebumps
How does trial enrollment work? Does big pharma kick back money to doctors to trial their drug? Do they kick back to the hospital?

When a drug like Remdesivir is showing poor at best results and yet dominates all the trials over and over since they continue to trial. Is that just to keep other drug companies from filling their very own trials and delay all other drugs to progress. Is this about who has the most money to back their drug? Does this next huge trial enrollment show something better? Do you do finally find a trial that shows something good and cancel the trials that are not working like Gilead has canceled multiple trials where they weren’t performing well. The next large trial with 5600 worldwide to be enrolled soon by Gilead. Is it preventing better drugs from progressing and therefore killing people? Is there blood on Gileads hands? The FDA for promoting such a minimal successful drug? This is what it seems and why does the federal government allow such a treachery? Buying your own trial results.

Link: https://www.bizjournals.com/sanfrancisco/news...t-and.html

Quote from article:

What now? Gilead likely will get accelerated approval. Meanwhile, it added an expansion phase of its study that will enroll an additional 5,600 patients at 180 trial sites globally. A second SIMPLE study is looking at the safety and efficacy of five- and 10-day treatments of remdesivir in patients with "moderate" Covid-19, with the results from the first 600 in that study expected by the end of May.


(2)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us